Changes in the etiology of chronic liver disease by referral to a FibroScan center: Increasing prevalence of the nonalcoholic fatty liver disease

Creative Commons License

Eris T., Hassan M., Hikal Y., Sawah E., Daneshgar F., Teker A. G., ...Daha Fazla

HEPATOLOGY FORUM, cilt.4, sa.1, ss.7-13, 2023 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 4 Sayı: 1
  • Basım Tarihi: 2023
  • Doi Numarası: 10.14744/hf.2022.2022.0042
  • Dergi Adı: HEPATOLOGY FORUM
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.7-13
  • Anahtar Kelimeler: Chronic liver disease, indications, liver fibrosis, CONTROLLED ATTENUATION PARAMETER, HEPATIC STEATOSIS, STIFFNESS MEASUREMENT, TURKEY, STEATOHEPATITIS, CARE, HBV
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Hayır

Özet

Background and Aim: Chronic liver disease (CLD) is a leading cause of morbidity and mortality worldwide with a wide etiological spectrum. Fi-broScan (R) is used for follow-up of fibrosis and steatosis. This single -cen-ter study aims to review the distribution of indications by referral to Fi-broScan (R).Materials and Methods: Demographic characteristics, CLD etiolo-gies, and FibroScan (R) parameters of the patients who were referred to our tertiary care center between 2013 and 2021 were retrospectively evaluated.Results: Out of 9345 patients, 4946 (52.93%) were males, and the medi-an age was 48 [18-88] years. Nonalcoholic fatty liver disease (NAFLD) was the most common indication (N=4768, 51.02%), followed by hepa-titis B (N=3194, 34.18%) and hepatitis C (N=707, 7.57%). Adjusting for age, sex, and CLD etiology, the results revealed that patients with old-er age (Odds ratio (OR)=2.908; confidence interval (CI)=2.597-3.256; p<0.001) and patients with hepatitis C (OR=2.582; CI=2.168-3.075; p<0.001), alcoholic liver disease (OR=2.019; CI=1.524-2.674, p<0.001), and autoimmune hepatitis (OR=2.138; CI=1.360-3.660, p<0.001) had increased odds of advanced liver fibrosis compared to NAFLD.Conclusion: NAFLD was the most common indication for referral to FibroScan (R).